HELENE HENDRIXSON: CANCER SURVIVOR
(- 2 -)
In other words, even with conventional treatment, the
outlook for Helene was not encouraging.
To make matters worse, her doctor held out little
hope that these conventional means would help. Her
cancer was too advanced. He suggested she enter a
clinical trial at the National Cancer Institute – what
he didn’t tell her, however, was that only 5% of the
patients in Phase I clinical trials ever derive any
benefit from the experiment.
But Helene was not the type of person to throw in the
towel without a fight. She was determined to find a way
to beat the odds. Then in February, her aunt called with
an option that seemed to offer a ray of hope. She had
heard of an alternative treatment using the mineral
cesium and a highly concentrated form of the whole leaf
of the aloe vera plant that was having considerable
success.
She decided to take a chance.
In April, she began taking the cesium according to
the High pH protocol.
The following month she began taking the aloe vera
concentrate.
Meanwhile, Helen’s doctor had arranged for her to
enter a clinical trial sponsored by the National Cancer
Institute.
The trial was named “Phase I Adjuvant Study of
Tumor-Derived Immunoglobulin Ideotype Combined with
QS-21 for Follicular Lymphomas.”
Its purpose was to determine if it were possible to
combine chemotherapy with a vaccine to treat the type of
non-Hodgkins Lymphoma that Helene had developed.
Continued -->
Helen Hendrixson: Cancer
Survivor 1 -
2 -
3 -
4 -
5
Click here to order
